Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.58 $5.85 Wednesday, 8th May 2024 CTMX stock ended at $4.19. This is 2.95% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.95% from a day low at $3.79 to a day high of $4.21.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Sep 14, 2016 $14.16 $15.64 $14.08 $15.60 201 500
Sep 13, 2016 $13.70 $14.20 $13.51 $14.01 117 900
Sep 12, 2016 $12.84 $13.79 $12.84 $13.76 133 700
Sep 09, 2016 $12.69 $13.57 $11.84 $12.99 112 200
Sep 08, 2016 $12.76 $12.98 $12.41 $12.84 144 500
Sep 07, 2016 $12.97 $12.98 $12.44 $12.74 113 600
Sep 06, 2016 $12.04 $13.62 $12.04 $12.82 183 500
Sep 02, 2016 $11.81 $12.23 $11.63 $12.07 89 400
Sep 01, 2016 $11.82 $11.85 $11.41 $11.72 61 200
Aug 31, 2016 $11.68 $11.98 $11.38 $11.73 55 900
Aug 30, 2016 $11.41 $11.76 $11.36 $11.64 23 000
Aug 29, 2016 $11.48 $11.79 $11.23 $11.71 38 500
Aug 26, 2016 $11.58 $11.58 $10.98 $11.36 41 800
Aug 25, 2016 $11.28 $11.40 $10.80 $10.94 30 700
Aug 24, 2016 $11.80 $12.00 $11.20 $11.23 65 700
Aug 23, 2016 $11.15 $11.95 $11.12 $11.82 120 900
Aug 22, 2016 $10.69 $11.15 $10.27 $11.14 44 200
Aug 19, 2016 $10.90 $10.94 $10.57 $10.65 30 100
Aug 18, 2016 $10.79 $11.08 $10.53 $10.89 28 000
Aug 17, 2016 $11.17 $11.18 $10.87 $10.95 20 300
Aug 16, 2016 $11.09 $11.30 $10.96 $11.09 28 400
Aug 15, 2016 $11.23 $11.45 $11.11 $11.26 70 500
Aug 12, 2016 $10.90 $11.20 $10.80 $11.15 76 800
Aug 11, 2016 $10.88 $11.08 $10.66 $11.00 73 800
Aug 10, 2016 $10.95 $11.02 $10.65 $10.78 35 700
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT